

** Companies developing muscular distrophy treatments, PTC Therapeutics and Summit Therapeutics had their shares boosted on Wednesday by positive regu...


** Biopharmaceutical company's U.S.-listed shares up 2.7 pct at $10.20 ** Stock rises as much as 4.5 pct to $10.35, valuing company at $120.8 mln ** ...







